Efficacy of prophylactic treatment of intraocular pressure spikes due to intravitreal injections;Efficacité d'un traitement prophylactique hypotonisant dans l'hypertonie oculaire induite après injections intravitréennes

Journal Francais d'Ophtalmologie

Volumn 35, Issue 8, 2012, Pages 614-621

  El Chehab, H ^a   Le Corre, A ^a   Giraud, J M ^a   Ract Madoux, G ^a   Swalduz, B ^a   Dot, C ^a  

^a HIA Desgenettes   (France)

Author keywords

Anti VEGF; Intraocular pressure; Intravitreal injection; IOP lowering medications

Indexed keywords

ACETAZOLAMIDE; ANTIHYPERTENSIVE AGENT; APRACLONIDINE; BEVACIZUMAB; BRIMONIDINE; CLONIDINE; DORZOLAMIDE PLUS TIMOLOL; DRUG DERIVATIVE; HYPOTONIC SOLUTION; MONOCLONAL ANTIBODY; QUINOXALINE DERIVATIVE; SULFONAMIDE; THIOPHENE DERIVATIVE; TIMOLOL;

AGED; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL TRIAL; DRUG COMBINATION; DRUG EFFECT; FEMALE; HUMAN; INTRAOCULAR HYPERTENSION; INTRAOCULAR PRESSURE; INTRAVITREAL DRUG ADMINISTRATION; MALE; METHODOLOGY; OCULOPLETHYSMOGRAPHY; PHYSIOLOGY; RETINA MACULA DEGENERATION; TREATMENT OUTCOME;

ACETAZOLAMIDE; AGED; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIHYPERTENSIVE AGENTS; CHEMOPREVENTION; CLONIDINE; DRUG COMBINATIONS; FEMALE; HUMANS; HYPOTONIC SOLUTIONS; INTRAOCULAR PRESSURE; INTRAVITREAL INJECTIONS; MACULAR DEGENERATION; MALE; OCULAR HYPERTENSION; QUINOXALINES; SULFONAMIDES; THIOPHENES; TIMOLOL; TONOMETRY, OCULAR; TREATMENT OUTCOME;

EID: 84867331235     PISSN: 01815512     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jfo.2012.02.009     Document Type: Article

References (24)

1. S.J. Bakri, J.S. Pulido, C.A. McCannel, D.O. Hodge, N. Diehl, and J. Hillemeier Immediate intraocular pressure changes following intravitreal injections of triamcinolone, pegaptanib, and bevacizumab Eye 23 2009 181 185
2. J.E. Kim, A.V. Mantravadi, E.Y. Hur, and D.J. Covert Short-term intraocular pressure changes immediately after intravitreal injections of anti-vascular endothelial growth factor agents Am J Ophthalmol 146 2008 930 934
3. L. Wu, and T. Evans Immediate changes in intraocular pressure after an intravitreal injection of 2.5 mg of bevacizumab Arch Soc Esp Oftalmol 85 2010 364 369
4. T.S. Chang, N.M. Bressler, J.T. Fine, C.M. Dolan, J. Ward, and T.R. Klesert Improved vision-related function after ranibizumab treatment of neovascular age-related macular degeneration: results of a randomized clinical trial Arch Ophthalmol 125 2007 1460 1469
5. D.M. Brown, P.K. Kaiser, M. Michels, G. Soubrane, J.S. Heier, and R.Y. Kim Ranibizumab versus verteporfin for neovascular age-related macular degeneration N Engl J Med 355 2006 1432 1444
6. G.A. Lalwani, P.J. Rosenfeld, A.E. Fung, S.R. Dubovy, S. Michels, and W.J. Feuer A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO study Am J Ophthalmol 148 2009 43 58
7. H. Hollands, J. Wong, R. Bruen, R.J. Campbell, S. Sharma, and J. Gale Short-term intraocular pressure changes after intravitreal injection of bevacizumab Can J Ophthalmol 42 2007 807 811
8. P.E. Theoulakis, P.E. Theoulakis, J. Lepidas, I.K. Petropoulos, A. Livieratou, and C.K. Brinkmann Effect of brimonidine/timolol fixed combination on preventing the short-term intraocular pressure increase after intravitreal injection of ranibizumab Klin Monbl Augenheilkd 227 2010 280 284
9. H. Kerimoglu, B.T. Ozturk, B. Bozkurt, M. Okka, and S. Okudan Does lens status affect the course of early intraocular pressure and anterior chamber changes after intravitreal injection? Acta Ophthalmologica 89 2011 138 142
10. M. Gismondi, C. Salati, M.L. Salvetat, M. Zeppieri, and P. Brusini Short-term effect of intravitreal injection of ranibizumab (Lucentis) on intraocular pressure J Glaucoma 18 2009 658-661
11. D.E. Silverstone, S.F. Brint, K.W. Olander, R.B. Taylor, G.R. McCarty, and J.M. deFaller Prophylactic use of apraclonidine for intraocular pressure increase after Nd:YAG capsulotomies Am J Ophthalmol 113 1992 401 405
12. o5015/A616.
13. M.P. Frenkel, S.A. Haji, and R.E. Frenkel Effect of prophylactic intraocular pressure-lowering medication on intraocular pressure spikes after intravitreal injections Arch Ophthalmol 128 2010 1523 1527
14. H.D. Jampel, A.L. Robin, H.A. Quigley, and I.P. Pollack Apraclonidine. A one-week dose-response study Arch Ophthalmol 106 1988 1069 1073
15. B.R. Friedland, J. Mallonee, and D.R. Anderson Short-term dose-response characteristics of acetazolamide in man Arch Ophthalmol 95 1977 1809 1812
16. K.C. Chan, A. Poostchi, T. Wong, N. Sachdev, and A.P. Wells Visual field changes after transient elevation of intraocular pressure in eyes with and without glaucoma Ophthalmology 115 2008 667 672
17. M.D. Bushley, V.C. Parmley, and P. Paglen Visual field defect associated with laser in situ keratomileusis Am J Ophthalmol 129 2000 668 671
18. A. Hirata, N. Yonemura, T. Hasumura, Y. Murata, and A. Negi Effect of infusion air pressure on visual field defects after macular hole surgery Am J Ophthalmol 130 2000 611 616
19. S. Asrani, R. Zeimer, J. Wilensky, D. Gieser, S. Vitale, and K. Lindenmuth Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma J Glaucoma 9 2000 134 142
20. o5123/D1119.
21. K.M. Joos, M.D. Kay, L.E. Pillunat, A. Harris, E. Kym Gendron, and W.J. Feuer Effect of acute intraocular pressure changes on short posterior ciliary artery haemodynamics Br J Ophthalmol 83 1999 33 38
22. H. Yang, H. Thompson, M.D. Roberts, I.A. Sigal, J.C. Downs, and C.F. Burgoyne Deformation of the early glaucomatous monkey optic nerve head connective tissue following acute IOP elevation within 3-d histomorphometric reconstructions Invest Ophthalmol Vis Sci 52 2011 345 363
23. I.A. Sigal, J.G. Flanagan, I. Tertinegg, and C.R. Ethier Modeling individual-specific human optic nerve head biomechanics. Prt I: IOP-induced deformations and influence of geometry Biomech Model Mechanobiol 8 2009 85 98
24. A. Poostchi, T. Wong, K.C. Chan, L. Kedzlie, N. Sachdev, and S. Nicholas Optic disc diameter increases during acute elevations of intraocular pressure Invest Ophthalmol Vis Sci 51 2010 2313 2316